BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24529572)

  • 1. [Safe prescription recommendations for non steroidal anti-inflammatory drugs: Consensus document ellaborated by nominated experts of three scientific associations (SER-SEC-AEG)].
    Lanas A; Benito P; Alonso J; Hernández-Cruz B; Barón-Esquivias G; Perez-Aísa A; Calvet X; García-Llorente JF; Gobbo M; Gonzalez-Juanatey JR
    Gastroenterol Hepatol; 2014 Mar; 37(3):107-27. PubMed ID: 24529572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe prescription recommendations for non steroidal anti-inflammatory drugs: consensus document ellaborated by nominated experts of three scientific associations (SER-SEC-AEG).
    Lanas A; Benito P; Alonso J; Hernández-Cruz B; Barón-Esquivias G; Perez-Aísa Á; Calvet X; García-Llorente JF; Gobbo M; Gonzalez-Juanatey JR; ; ;
    Reumatol Clin; 2014; 10(2):68-84. PubMed ID: 24462644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].
    Rossini R; Lucà MG; Scuri P; Invernizzi P; Strazzabosco M; Gavazzi A
    Ital Heart J Suppl; 2005 Oct; 6(10):621-6. PubMed ID: 16273749
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association.
    Antman EM; Bennett JS; Daugherty A; Furberg C; Roberts H; Taubert KA;
    Circulation; 2007 Mar; 115(12):1634-42. PubMed ID: 17325246
    [No Abstract]   [Full Text] [Related]  

  • 5. [Appropriate prescription, adherence and safety of non-steroidal anti-inflammatory drugs].
    Sostres C; Lanas Á
    Med Clin (Barc); 2016 Mar; 146(6):267-72. PubMed ID: 26724872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective COX-2 inhibitors: a promise unfulfilled?
    Henry D; McGettigan P
    Gastroenterology; 2007 Feb; 132(2):790-4. PubMed ID: 17261306
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nonsteroidal anti-inflammatory agents--choice between disturbances of gastrointestinal tract and cardiovascular toxicity].
    Gumbrevicius G; Milasius A; Sveikata A
    Medicina (Kaunas); 2006; 42(5):429-39. PubMed ID: 16778472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [First Spanish consensus on peptic ulcer bleeding management. Consenso sobre Hemorragia Digestiva por Úlcera Péptica].
    Lanas A; Calvet X; Feu F; Ponce J; Gisbert JP; Barkun A;
    Med Clin (Barc); 2010 Nov; 135(13):608-16. PubMed ID: 20846695
    [No Abstract]   [Full Text] [Related]  

  • 9. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.
    Hippisley-Cox J; Coupland C; Logan R
    BMJ; 2005 Dec; 331(7528):1310-6. PubMed ID: 16322018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gastrointestinal bleeding during low dose acetylsalicylic acid. Is Godamed-100 TAH an alternative to conventional ASS preparations?].
    Maywald U; Schindler C
    Dtsch Med Wochenschr; 2005 Apr; 130(16):1026-7. PubMed ID: 15830316
    [No Abstract]   [Full Text] [Related]  

  • 12. [NSAID therapy. Gastrointestinal risks of classic NSAID are underestimated].
    MMW Fortschr Med; 2010 May; 152(20):46-7. PubMed ID: 20552882
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of peptic ulceration in patients receiving NSAIDs.
    Ballinger A
    Br J Hosp Med; 1993 Jun 2-15; 49(11):767-72. PubMed ID: 8101464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSAIDs--the two-edged sword.
    Melzer E; Bar-Meir S
    Isr J Med Sci; 1993 May; 29(5):316-7. PubMed ID: 8314697
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonsteroidal anti-inflammatory drugs, aspirin, and gastrointestinal prophylaxis: an ounce of prevention.
    Scheiman JM
    Rev Gastroenterol Disord; 2005; 5 Suppl 2():39-49. PubMed ID: 16369226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology of NSAID associated gastrointestinal disease.
    Wolfe F
    Eur J Rheumatol Inflamm; 1991; 11(3):12-28. PubMed ID: 1365476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention and treatment of upper gastrointestinal bleeding by nonsteroidal anti-inflammatory drugs].
    Bar-Dayan Y; Levi Y
    Harefuah; 1996 Apr; 130(8):535-7. PubMed ID: 8765878
    [No Abstract]   [Full Text] [Related]  

  • 18. [How to reduce the risks of NSAIDs].
    Gross M
    MMW Fortschr Med; 2008 Jul; 150(28-31):50-3; quiz 54. PubMed ID: 19006892
    [No Abstract]   [Full Text] [Related]  

  • 19. [Not Available].
    Korsten P; Müller GA
    Dtsch Med Wochenschr; 2017 Nov; 142(23):1775-1777. PubMed ID: 29145684
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease.
    Joshua FF; Oakley SP; Major GA
    Intern Med J; 2004 Apr; 34(4):153-61. PubMed ID: 15086694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.